Bal Pharma bulk deals, insider trading and stake changes
NSE: BALPHARMABSE: 524824Pharmaceuticals & BiotechnologySmall Cap
Bal Pharma Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, May 2006 on NSE
Last close ₹83.04up ₹3.94 (4.98%)BSE ₹82.35
Share price at the NSE close on 27 Oct 2026. Previous close ₹79.10.
27 Oct: open ₹79.00, high ₹83.05, low ₹79.00
52-week range of traded prices to 27 Oct 2026
₹60.00Low, 30 Mar 2026₹124.60High, 10 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹132 Cr2,779th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 18.35
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.61
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.45%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.94
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 11,344
Bal Pharma's insiders have 34 trade disclosures on record, the latest on 24 Jun 2026. Its promoter group made no purchase or sale on the market in the 12 months to 27 Oct 2026.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Bal Pharma promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Bal Pharma insider trading
The company's own latest disclosure on record is from Apr 2022.Insider trading, all companies
Jun 2026
- SHAILESH SIROYA₹21 Cr23,70,759 sharesSold or invoked · Promoter · 18 Jun 2026 · disclosed 24 Jun
- SHAILESH SIROYA₹21 Cr23,70,759 sharesBought · Promoter · 18 Jun 2026 · disclosed 24 Jun
- SHAILESH SIROYA₹3.23 Cr3,74,700 sharesSold or invoked · Promoter · 12 Jun 2026 · disclosed 17 Jun
- SHAILESH SIROYA₹3.23 Cr3,74,700 sharesBought · Promoter · 12 Jun 2026 · disclosed 17 Jun
Sep 2024
- HIMESH VIRURAKSHYA₹0.07 Cr5,000 sharesSold or invoked · Designated Person · 3 Sep 2024 · disclosed 2 Feb 2025
- HIMESH VIRURAKSHYA₹0.08 Cr5,530 sharesBought · Designated Person · 2 Sep 2024 · disclosed 2 Feb 2025
Jun 2023
- HIMESH VIRURAKSHYA₹0.11 Cr12,000 sharesSold or invoked · Designated Person · 1 Jun 2023 · disclosed 5 Jun
May 2022
- SHAILESH SIROYA₹7.61 Cr7,50,000 sharesBought · Designated Person · 17 May 2022 · disclosed 23 Aug
Apr 2022
- SHAILESH SIROYA₹3.75 Cr7,50,000 sharesReceived · Promoters · 13 Apr 2022 · Preferential Offer · held 19,95,459 before, holds 27,45,459 after, stake 17.63% after
Nov 2021
- MICRO LABS LIMITED₹3.70 Cr4,00,000 sharesBought · 23 Nov 2021 · disclosed 24 Nov · stake 10.87% before, 13.57% after
Aug 2021
1 entry
- MICRO LABS LIMITED₹0.03 Cr3,00,900 sharesBought · Promoters · 27 Aug 2021 · stake 8.84% before, 10.87% after
Mar 2021
1 entry
- SHAILESH SIROYA₹3.25 Cr6,50,000 sharesReceived · Promoters · 17 Mar 2021 · disclosed 22 Mar · Preferential Offer · held 13,45,459 before, holds 19,95,459 after
Apr 2019
13 entries
- SHRENIK D SIROYA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others
- ARCHANA SURANA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 2.01% before, 2.01% after
- DILIP SURANA (HUF)0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 1.19% before, 1.19% after
- SUBBARAO PRASANNA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 0.14% before, 0.14% after
- ANITA SIROYA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 7.40% before, 7.40% after
- SHAILESH D SIROYA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 9.49% before, 9.49% after
- ANAND SURANA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 3.71% before, 3.71% after
- MICRO LABS LIMITED0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 9.24% before, 9.24% after
- DILIP SURANA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 3.35% before, 3.35% after
- MONIKA SURANA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 1.26% before, 1.26% after
- CHANDRAPRAKASH DHEERAJMAL SIROYA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 3.43% before, 3.43% after
- ANITA CHANDRAPRAKASH SIROYA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 0.86% before, 0.86% after
- JIVI DHEERAJMAL SIROYA0sharesReceived · Promoters · 1 Apr 2019 · disclosed 31 Mar 2020 · Others · stake 0.32% before, 0.32% after
Sep 2018
2 entries
- SHREYA MARDIA₹2.70 Cr3,00,000 sharesReceived · Immediate relative · 26 Sep 2018 · disclosed 27 Sep · Gift · stake 0.01% before, 2.12% after
- SHAILESH D SIROYA₹2.70 Cr3,00,000 sharesGave · Director · 26 Sep 2018 · disclosed 27 Sep · Gift · stake 11.61% before, 9.49% after
Dec 2017
2 entries
- SHRENIK D SIROYA₹3.30 Cr3,74,700 sharesGave · Promoters · 7 Dec 2017 · disclosed 8 Dec · Inter-se-Transfer · held 3,74,700 before
- SHAILESH D SIROYA₹3.30 Cr3,74,700 sharesReceived · Promoters · 7 Dec 2017 · disclosed 8 Dec · Inter-se-Transfer · stake 8.96% before, 11.61% after
Jun 2017
4 entries
- ANITA SIROYA₹0.10 Cr10,000 sharesBought · Promoters · 23 Jun 2017 · disclosed 26 Jun · stake 7.33% before, 7.40% after
- ANITA SIROYA₹0.14 Cr13,427 sharesBought · Promoters · 19 Jun 2017 · disclosed 23 Jun · stake 7.23% before, 7.33% after
- ANITA SIROYA₹0.03 Cr3,440 sharesBought · Promoters · 19 Jun 2017 · disclosed 23 Jun · stake 7.23% before, 7.33% after
- ANITA SIROYA₹0.10 Cr9,987 sharesBought · Promoters · 19 Jun 2017 · disclosed 23 Jun · stake 7.23% before, 7.30% after
Apr 2017
1 entry
- ANITA SIROYA₹0.07 Cr7,269 sharesBought · Promoters · 18 Apr 2017 · disclosed 20 Apr · stake 7.18% before, 7.23% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Bal Pharma stake sales and purchases
All 12 disclosures on record.
Nov 2021
- AcquiredMicro Labs Limited · promoter2.70% of the company4,00,000 sharesholds 13.57% after23 Nov 2021 · filed under the 2% rule · Open Market
Aug 2021
- AcquiredMicro Labs Limited · promoter2.03% of the company3,00,900 sharesholds 10.87% after27 Aug 2021 · filed under the 2% rule · Open Market
Mar 2021
- AcquiredShailesh Siroya · promoter4.38% of the company6,50,000 sharesholds 13.46% after17 Mar 2021 · filed under the 2% rule · Preferential Allotment
Sep 2018
- SoldShailesh Siroya · promoter2.11% of the company3,00,000 sharesholds 9.49% after26 Sep 2018 · filed under the 2% rule
- AcquiredShreya Mardia2.11% of the company3,00,000 sharesholds 2.12% after26 Sep 2018 · filed under the 2% rule
- DisclosedShreya Mardiaholds 2.12% after26 Sep 2018 · filed under the 2% rule
- SoldShailesh Siroya · promoter2.11% of the company3,00,000 sharesholds 9.49% after26 Sep 2018 · filed under the 2% rule
Dec 2017
- SoldShrenik D Siroya · promoter2.64% of the company3,74,700 sharesholds none after7 Dec 2017 · filed under the 2% rule · Inter-se transfer
- AcquiredShailesh Siroya · promoter2.64% of the company3,74,700 sharesholds 11.61% after7 Dec 2017 · filed under the 2% rule · Inter-se transfer
Jun 2017
- AcquiredAnita Siroya · promoter0.07% of the company10,000 sharesholds 7.40% after23 Jun 2017 · filed under the 2% rule · Open Market
- AcquiredAnita Siroya · promoter0.10% of the company13,427 sharesholds 8.07% after22 Jun 2017 · filed under the 2% rule · Open Market
Apr 2017
1 entry
- AcquiredAnita Siroya · promoter0.05% of the company7,269 sharesholds 7.23% after19 Apr 2017 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Bal Pharma bulk deals
Last 12 months, since 28 Oct 2025: 4 bulk deals, ₹1.22 Cr bought and ₹1.17 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 21 Jul 20261 firm · ₹1.22 Cr bought · ₹1.17 Cr soldNet bought ₹0.05 Cr
- Both waysORION STOCKS LTDBought 1,36,398 at ₹89.59Sold 1,30,648 at ₹89.710.86% of the companyNet +5,750 shares₹1.22 Cr bought
Friday 4 Apr 20253 firms · ₹4.48 Cr bought · ₹4.48 Cr soldNet nil
- Both waysPARTH INFIN BROKERS PVT LTDBought 1,10,803 at ₹125.31Sold 1,10,803 at ₹124.360.70% of the companyNet nil₹1.39 Cr bought
- Both waysMUDUPULAVEMULA SURENDRANADHA REDDYBought 1,23,412 at ₹120.96Sold 1,23,412 at ₹121.510.78% of the companyNet nil₹1.49 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 1,32,023 at ₹121.03Sold 1,32,023 at ₹121.170.83% of the companyNet nil₹1.60 Cr bought
Friday 23 Aug 20241 firm · ₹1.24 Cr bought · ₹1.24 Cr soldNet nil
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 86,838 at ₹142.85Sold 86,838 at ₹143.070.55% of the companyNet nil₹1.24 Cr bought
Thursday 22 Aug 20241 firm · ₹1.22 Cr bought · ₹1.22 Cr soldNet nil
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 90,349 at ₹134.74Sold 90,349 at ₹134.930.57% of the companyNet nil₹1.22 Cr bought
Friday 28 Jul 20231 firm · ₹0.96 Cr bought · ₹0.69 Cr soldNet bought ₹0.27 Cr
- Both waysSANDEEP PRAKASHCHANDRA JAIN (HUF)Bought 96,847 at ₹99.16Sold 69,950 at ₹98.030.62% of the companyNet +26,897 shares₹0.96 Cr bought
Friday 21 Apr 20231 firm · ₹0.79 Cr bought · ₹0.79 Cr soldNet nil
- Both waysINDRA KIRAN VENTURESBought 89,559 at ₹88.14Sold 89,559 at ₹87.970.57% of the companyNet nil₹0.79 Cr bought
Wednesday 22 Mar 20232 firms · ₹0.70 Cr bought · ₹0.71 Cr soldNet sold ₹0.01 Cr
- SoldVEENA PARAKHSold 1,02,000 at ₹69.990.65% of the company₹0.71 Cr
- BoughtAJAY PARAKHBought 1,00,000 at ₹69.980.64% of the company₹0.70 Cr
Monday 25 Apr 20221 firm · ₹1.08 Cr bought · ₹1.08 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 84,200 at ₹128.15Sold 84,200 at ₹128.280.54% of the companyNet nil₹1.08 Cr bought
Thursday 20 Jan 20221 firm · ₹1.21 Cr bought · ₹1.21 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 84,760 at ₹142.73Sold 84,760 at ₹142.540.57% of the companyNet nil₹1.21 Cr bought
Monday 17 Jan 20222 firms · ₹3.33 Cr bought · ₹3.31 Cr soldNet bought ₹0.02 Cr
- Both waysXTX MARKETS LLPBought 1,14,344 at ₹138.68Sold 1,12,979 at ₹139.070.77% of the companyNet +1,365 shares₹1.59 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 1,25,782 at ₹138.93Sold 1,25,782 at ₹138.580.85% of the companyNet nil₹1.75 Cr bought
Tuesday 23 Nov 20213 firms · ₹3.70 Cr bought · ₹3.70 Cr soldNet nil
- BoughtMICRO LABS LTDBought 4,00,000 at ₹92.452.70% of the company₹3.70 Cr
- SoldVIPUL KUMATSold 2,73,704 at ₹92.401.85% of the company₹2.53 Cr
- SoldKUMAT VIPULSold 1,26,296 at ₹92.560.85% of the company₹1.17 Cr
Wednesday 15 Sep 20211 firm · ₹1.17 Cr bought · ₹0.86 Cr soldNet bought ₹0.31 Cr
- Both waysMUKUL MAHESHWARI (HUF)Bought 1,09,598 at ₹106.54Sold 80,416 at ₹107.210.74% of the companyNet +29,182 shares₹1.17 Cr bought
Monday 30 Aug 20211 firm · ₹0 bought · ₹1.03 Cr soldNet sold ₹1.03 Cr
- SoldMARDIA ATULSold 1,00,000 at ₹102.600.67% of the company₹1.03 Cr
Friday 27 Aug 20212 firms · ₹2.79 Cr bought · ₹2.79 Cr soldNet nil
- BoughtMICRO LABS LIMITEDBought 3,00,900 at ₹92.742.03% of the company₹2.79 Cr
- SoldJITENDRA TEJRAJ LUNIASold 3,00,900 at ₹92.732.03% of the company₹2.79 Cr
Friday 6 Aug 20211 firm · ₹17,414 bought · ₹0.72 Cr soldNet sold ₹0.72 Cr
- Both waysYUGA DOSHIBought 178 at ₹97.83Sold 74,592 at ₹97.120.50% of the companyNet −74,414 shares₹17,414 bought
Thursday 5 Aug 20211 firm · ₹0.91 Cr bought · ₹0.39 Cr soldNet bought ₹0.52 Cr
- Both waysYUGA DOSHIBought 88,326 at ₹103.32Sold 37,919 at ₹103.650.60% of the companyNet +50,407 shares₹0.91 Cr bought
Wednesday 28 Apr 20217 firms · ₹9.97 Cr bought · ₹10 Cr soldNet sold ₹0.19 Cr
- Both waysPRB SECURITIES PVT LTDBought 16,212 at ₹123.86Sold 77,437 at ₹120.480.55% of the companyNet −61,225 shares₹0.20 Cr bought
- Both waysPRB SECURITIES PVT. LTD.Bought 77,432 at ₹120.40Sold 16,207 at ₹123.940.55% of the companyNet +61,225 shares₹0.93 Cr bought
- Both waysTOPGAIN FINANCE PRIVATE LIMITEDBought 2,45,032 at ₹129.96Sold 2,45,032 at ₹134.711.73% of the companyNet nil₹3.18 Cr bought
- Both waysAJAY DESAI (HUF)Bought 76,223 at ₹121.92Sold 76,223 at ₹130.190.54% of the companyNet nil₹0.93 Cr bought
- Both waysDIPAN MEHTA COMMODITIES PRIVATE LIMITEDBought 97,045 at ₹127.57Sold 97,045 at ₹127.980.68% of the companyNet nil₹1.24 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 1,94,157 at ₹125.05Sold 1,94,157 at ₹125.251.37% of the companyNet nil₹2.43 Cr bought
- Both waysQE SECURITIESBought 86,243 at ₹123.16Sold 86,243 at ₹123.440.61% of the companyNet nil₹1.06 Cr bought
Tuesday 27 Apr 20211 firm · ₹1.48 Cr bought · ₹1.50 Cr soldNet sold ₹0.01 Cr
- Both waysALPHA LEON ENTERPRISES LLPBought 1,21,157 at ₹122.42Sold 1,19,457 at ₹125.190.85% of the companyNet +1,700 shares₹1.48 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. The latest 56 deals, on record from 4 Jan 2004.